Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Matthias Zentgraf is active.

Publication


Featured researches published by Matthias Zentgraf.


Synthetic Communications | 2001

AN IMPROVED SYNTHETIC PROCEDURE FOR 6,6′-DIBROMOINDIGO (TYRIAN PURPLE)

Peter Imming; Ingo Imhof; Matthias Zentgraf

Tyrian purple was the most precious dye of antiquity. We describe a simple synthetic procedure that yields the actual dye, 6,6′-dibromoindigo 1, in considerably improved overall yield and of analytical purity, also being amenable to scale-up.


Acta Crystallographica Section D-biological Crystallography | 2010

Structure and substrate docking of a hydroxy(phenyl)pyruvate reductase from the higher plant Coleus blumei Benth.

Verena Janiak; Maike Petersen; Matthias Zentgraf; Gerhard Klebe; Andreas Heine

Hydroxy(phenyl)pyruvate reductase [H(P)PR] belongs to the family of D-isomer-specific 2-hydroxyacid dehydrogenases and catalyzes the reduction of hydroxyphenylpyruvates as well as hydroxypyruvate and pyruvate to the corresponding lactates. Other non-aromatic substrates are also accepted. NADPH is the preferred cosubstrate. The crystal structure of the enzyme from Coleus blumei (Lamiaceae) has been determined at 1.47 A resolution. In addition to the apoenzyme, the structure of a complex with NADP(+) was determined at a resolution of 2.2 A. H(P)PR is a dimer with a molecular mass of 34 113 Da per subunit. The structure is similar to those of other members of the enzyme family and consists of two domains separated by a deep catalytic cleft. To gain insights into substrate binding, several compounds were docked into the cosubstrate complex structure using the program AutoDock. The results show two possible binding modes with similar docking energy. However, only binding mode A provides the necessary environment in the active centre for hydride and proton transfer during reduction, leading to the formation of the (R)-enantiomer of lactate and/or hydroxyphenyllactate.


ChemMedChem | 2009

Structure-Based Optimization of Aldose Reductase Inhibitors Originating from Virtual Screening

Michael Eisenmann; Holger Steuber; Matthias Zentgraf; Mirko Altenkämper; Regina Ortmann; Johann Perruchon; Gerhard Klebe; Martin Schlitzer

Virtual screening discovered two prospective hits as potential leads for aldose reductase inhibition. Based on their crystal structures with the enzyme, a systematic optimization has been performed to reveal a first structure–activity relationship. A central thiophen moiety and a terminal nitro group exhibit the best binding properties.


Journal of Molecular Biology | 2006

Expect the Unexpected or Caveat for Drug Designers: Multiple Structure Determinations Using Aldose Reductase Crystals Treated under Varying Soaking and Co-crystallisation Conditions

Holger Steuber; Matthias Zentgraf; Christof Gerlach; Christoph A. Sotriffer; Andreas Heine; Gerhard Klebe


Journal of Medicinal Chemistry | 2011

A small nonrule of 3 compatible fragment library provides high hit rate of endothiapepsin crystal structures with various fragment chemotypes.

Helene Köster; Tobias Craan; Sascha Brass; Christian Herhaus; Matthias Zentgraf; Lars Neumann; Andreas Heine; Gerhard Klebe


Archive | 2008

Aryl-and Heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use

Frank Himmelsbach; Matthias Eckhardt; Bradford S. Hamilton; Armin Heckel; Joerg Kley; Thorsten Lehmann-Lintz; Herbert Nar; Stefan Peters; Annette Schuler-Metz; Matthias Zentgraf


Journal of Molecular Biology | 2006

High-resolution crystal structure of aldose reductase complexed with the novel sulfonyl-pyridazinone inhibitor exhibiting an alternative active site anchoring group.

Holger Steuber; Matthias Zentgraf; Alberto Podjarny; Andreas Heine; Gerhard Klebe


Angewandte Chemie | 2007

How Reliable Are Current Docking Approaches for Structure-Based Drug Design? Lessons from Aldose Reductase

Matthias Zentgraf; Holger Steuber; Cornelia Koch; Concettina La Motta; Stefania Sartini; Christoph A. Sotriffer; Gerhard Klebe


Journal of Molecular Biology | 2007

Evidence for a Novel Binding Site Conformer of Aldose Reductase in Ligand-Bound State

Holger Steuber; Matthias Zentgraf; Concettina La Motta; Stefania Sartini; Andreas Heine; Gerhard Klebe


Angewandte Chemie | 2007

Wie verlässlich sind aktuelle Docking‐Ansätze für strukturbasiertes Wirkstoffdesign? – Fallstudie zur Aldose‐Reduktase

Matthias Zentgraf; Holger Steuber; Cornelia Koch; Concettina La Motta; Stefania Sartini; Christoph A. Sotriffer; Gerhard Klebe

Collaboration


Dive into the Matthias Zentgraf's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge